2004-2006

2006

• Gardiner, J., Thomae, A. V., Mathad, R. I., Seebach, D., Krämer, S. D. (2006) Comparison of permeation through phosphatidylcholine bilayers of N-dipicolinyl-alpha- and beta-oligopeptides. Chem. Biodiv. 3, 1181-1201
  
  
• Testa, B., Krämer, S. D. (2006) The biochemistry of drug metabolism - An introduction: Part 1. Principles and overview. Chem. Biodiv. 3, 1053-1101
  
  
• Krämer, S. D. (2006) Lipid bilayers in ADME: Permeation barriers and distribution compartments. In: Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies. Eds.: B. Testa, S. D. Krämer, H. Wunderli-Allenspach, G. Folkers. Wiley-VCH, Weinheim
  
  
• Hermann, D. M., Kilic, E., Spudich, A., Krämer, S. D., Wunderli-Allenspach, H., Bassetti, C. L. (2006) Role of drug efflux carriers in the healthy and diseased brain. Ann Neurol. 60, 489-98.
  
  
• Hermann, D. M., Kilic, E., Krämer, S. D., Wunderli-Allenspach, H., Bassetti, C. L. (2006) ATP-binding cassette transporters: Therapeutic targets in brain diseases. Ann. Neurol. 60, 489-498.
  
  
• Spudich, A., Kilic, E., Xing, H., Kilic, U., Rentsch, K. M., Wunderli-Allenspach, H., Bassetti, C. L., Hermann, D. M. (2006) Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat. Neurosci. 9, 487-488.
  
  
• Wunderli-Allenspach, H. (2006) In vivo pharmacokinetic profiling of drugs. In: Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies. Eds.: B. Testa, S. D. Krämer, H. Wunderli-Allenspach, G. Folkers. Wiley-VCH, Weinheim.
  
  

2005

• Thomae, A. V., Wunderli-Allenspach, H., Krämer, S. D. (2005) Permeation of aromatic carboxylic acids across lipid bilayers: the pH-partition hypothesis revisited.  Biophys J., 89, 1802-1811
  
  
• Kamau, S.,Krämer, S. D., Günthert, M., Wunderli-Allenspach, H. (2005) Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in mdr1-MDCK cells. In Vitro Cell. Dev. Biol.-Animal, 41, 207-216
  
  
• Bucher, K., Besse, C. A., Kamau, S. W., Wunderli-Allenspach, H., Krämer, S. D. (2005) Isolated rafts from adriamycin-resistant P388 cells contain functional ATPases and provide an easy test system for P Glycoprotein-related activities. Pharm. Res., 22, 449-457.

2004

• Langguth, P., Fricker, G., Wunderli-Allenspach, H. (2004) Biopharmazie. Wiley-VCH, Weinheim.
  
  
• Marenchino, M., Alpstäg-Wöhrle, A. L., Christen, B., Wunderli-Allenspach, H., Krämer, S. D. (2004) alpha-Tocopherol influences the lipid membrane affinity of desipramine in a pH-dependent manner. Eur. J. Pharm. Sci. 21, 313-321.
  
  
• Feige K., Dennler M., Kastner S.B., Wunderli-Allenspach, H., Demuth D., Huber A. (2004) Pharmacokinetics of recombinant hirudin in healthy horses. Equine Vet. J. 36, 135-141.
  
  
• Wunderli-Allenspach, H., Bucher, K., Hofmann, J., Marenchino, M., Thomae, A., Günthert, M., Krämer, S. D, (2004) Exploring barrier mechanisms relevant for drug therapy. Chimia, 58, 741-744.
  
  
• Sticher O., Wunderli-Allenspach, H. (2004) Pharmacy at the ETH Zurich - Past and present. Chimia, 58, 681-683.
  
  
• Wunderli-Allenspach, H. (2004) From Pharmacy to Pharmaceutical Sciences - The new curriculum. Chimia, 58, 684-685